Embody, Inc., a privately-held medical device company focused on soft tissue repair, announced that it has closed a $9.3 million Series A funding round with participation from cultivate(MD).
The financing will enable Embody to expand its world-class team and the commercial launch Tapestry®, its next-generation soft-tissue repair technology in the second half of 2020.